FDA CertificateFDA Certificate

Origin secures FDA licence to export registered medical products to the US

Posted on2nd September 2020 By Origin 15 Mins

Origin, has secured a licence to export registered medical products to the U.S from the U.S Food and Drug Administration.

The Certificate of Drug Establishment Registration has been issued by Registrar Corp for alcohol-based antibacterial hand sanitiser gel. Origin has secured an initial co-order of 15 million units which will be filled and packaged at its state-of-the-art facility in Melton, East Yorkshire before being distributed to U.S partners.

Hand hygiene, including the use of hand sanitisers, is an important action as part of efforts to stop the spread of the SARS-CoV-2. As such, demand for personal hygiene products continues to grow globally amid the ongoing Covid-19 pandemic, with the international hand sanitiser market expected to reach $1.87 Billion by the end of 2020. This high demand has led to many retailers increasing the price of this essential commodity and new companies entering the market, particularly alcohol manufacturers.

The hand sanitiser market has two segments – alcohol-based sanitiser and alcohol-free sanitiser. Both types play a vital role in preventing the spread of many disease microorganisms including Coronaviruses. For the current Covid-19 pandemic, the Centers for Disease Control and Prevention (CDC) recommends 60-95% alcohol-based hand sanitisers, particularly in healthcare settings.

Rich Quelch, Global Head of Marketing at Origin commented:

“From the outset of the Covid-19 crisis, Origin has committed to help mitigate the devastating impact of the virus internationally. We’re delighted to be able to support the production of much-needed alcohol-based hand sanitiser gel in our state-of-the-art filling and packaging facility in East Yorkshire and receive FDA approval for U.S distribution.

 “Origin has a long history of manufacturing and supplying healthcare packaging globally, and we’re very interested in expanding our relationships with partners for skincare, healthcare and pharma products in the U.S and other international markets. This FDA licence marks an important step forward in realising this goal.”

Posted on2nd September 2020 By Origin 15 Mins

Related Posts

VIEW ALL Posts
Why Child-Resistant Vape Packaging is a Non-Negotiable
Child Safe Packaging

Why Child-Resistant Vape Packaging is a Non-Negotiable

As the vape industry continues to grow, the need for dependable packaging that bears the needs of its users in mind becomes increasingly important. Specifically, packaging that prevents the risk of harm to children through unintended use of vape products is imperative. To meet this need, using child-resistant packaging is not only an ethical responsibility…

Posted on15th May 2026 ByJon Lant 15 Mins
Maintaining Quality: Origin’s Guide to Keeping Medical Cannabis Fresh
Product Guides

Maintaining Quality: Origin’s Guide to Keeping Medical Cannabis Fresh

As the commonality of medical cannabis continues to increase in the UK, keeping dried medical cannabis flower is essential to ensure the longevity and safety of prescribed medication. As medical cannabis packaging plays a significant part, there are specific qualities to bear in mind that mean that certain qualities are favoured for preservation. Below, we…

Posted on28th April 2026 ByJon Lant 15 Mins
Glass vs PET: Choosing the Right Material for Your CBD Oil
Materials

Glass vs PET: Choosing the Right Material for Your CBD Oil

When choosing packaging for CBD oil products, the two most common choices are glass and PET (polyethylene terephthalate) bottles. Each of these materials offers unique benefits and is popular as a result. However, this can make choosing between the two difficult without full knowledge of their benefits and drawbacks. In this blog, we cover the…

Posted on23rd April 2026 ByJon Lant 15 Mins

Don't miss a thing from Origin.

Fill in your details below to be added to our mailing list.

×